Prestige Consumer Healthcare (PBH) Liabilities and Shareholders Equity (2011 - 2025)

Prestige Consumer Healthcare's Liabilities and Shareholders Equity history runs 15 years deep, the most recent figure standing at $3.5 billion for Q4 2025.

• On a quarterly basis, Liabilities and Shareholders Equity rose 4.96% year-over-year to $3.5 billion in Q4 2025; TTM through Dec 2025 was $13.8 billion, a 3.76% increase from a year earlier, with the FY2025 full-year figure at $3.4 billion, up 2.53% from the prior year.
• Liabilities and Shareholders Equity advanced to $3.5 billion in Q4 2025 per PBH's latest filing, from $3.4 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $3.7 billion in Q4 2022 and bottomed at $3.3 billion in Q2 2024.
• The 5-year median for Liabilities and Shareholders Equity is $3.4 billion (2021), against an average of $3.5 billion.
• Across the five-year window, Liabilities and Shareholders Equity advanced 7.04% in 2022 and retreated 10.93% in 2023, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $3.7 billion in 2021, then increased by 2.47% to $3.7 billion in 2022, then dropped by 10.93% to $3.3 billion in 2023, then decreased by 0.31% to $3.3 billion in 2024, then gained by 4.96% to $3.5 billion in 2025.
• Per Business Quant, the three latest PBH Liabilities and Shareholders Equity figures stand at $3.5 billion (Q4 2025), $3.4 billion (Q3 2025), and $3.4 billion (Q2 2025).